Amanda Ribas had the opportunity to make a career for herself in the world’s biggest MMA promotion — the UFC!
Unfortunately, she’s going to have to wait another two years for that chance.
Ribas tested positive for the drug, Ostarine, reported MMA Fighting.
According to the USADA:
Ostarine, also known as MK-2866 and Enobosarm, is a non-FDA approved selective androgen receptor modulator (SARM) that is illegally sold in the United States and worldwide as a performance-enhancing substance. Ostarine is not currently available as a prescription medication in any country, and its unauthorized use may carry serious side effects.
Ribas tested positive during an out-of-competition sample collected on June 7, 2017.
She was supposed to make her debut last year at TUF 25, but was removed from the card for a provisional suspension.
With a 6-1 record and all but one of her victories coming by way of finish, Amanda could have been a force to be reckoned with in the UFC’s strawweight division.
Unfortunately, we may never know what damage she would be capable of in the UFC. At the very least, we will have to wait until June 7, 2019.